XML 54 R40.htm IDEA: XBRL DOCUMENT v3.20.4
Stock Plans (Tables)
12 Months Ended
Dec. 31, 2020
Stock Plans [Abstract]  
Summary of Weighted-Average Fair-Value and Vesting of Restricted Stock Grants

2020

2019

2018

Weighted-

average

average

Shares

average grant

Shares

grant date

Shares

grant date

granted

date fair value

granted

fair value

granted

fair value

Director plan

6,000

(2)

$

56.63

5,600

(2)

$

54.69

8,400

(2)

$

49.50

Omnibus plan

11,761

(3)

55.06

7,251

(2)

54.69

10,800

(2)

45.83

Omnibus plan

50

(1)

57.62

50

(1)

58.08

50

(1)

49.50

Omnibus plan

500

(2)

34.02

-

-

-

-

Total

18,311

$

55.00

12,901

$

54.70

19,250

$

47.44

(1)Vest after 1 year (2) Vest after 3 years – 33% each year (3) Vest fully after 3 years

Schedule of Non-Vested Restricted Stock Units Activity

2012 Stock incentive plans

Director

Omnibus

Total

Weighted- average grant date fair value

Non-vested balance at December 31, 2017

8,400

12,304

20,704

$

23.59

Granted

8,400

10,850

19,250

47.44

Vested

(4,200)

(5,794)

(9,994)

23.69

Non-vested balance at December 31, 2018

12,600

17,360

29,960

$

38.99

Granted

5,600

7,301

12,901

54.70

Forfeited

-

(126)

(126)

54.69

Vested

(7,000)

(8,574)

(15,574)

33.81

Non-vested balance at December 31, 2019

11,200

15,961

27,161

$

49.48

Granted

6,000

12,311

18,311

55.00

Vested

(7,798)

(7,597)

(15,395)

48.47

Non-vested balance at December 31, 2020

9,402

20,675

30,077

$

53.36

Schedule of SSARs Activity

Awards

Weighted-average grant date fair value

Weighted-average remaining contractual term (years)

Outstanding December 31, 2017

53,360

$

4.20

8.5

Granted

38,941

13.73

10.0

Exercised

(3,051)

4.03

Forfeited

-

-

Outstanding December 31, 2018

89,250

$

8.36

8.2

Granted

11,073

16.79

10.0

Exercised

(3,059)

3.48

Forfeited

-

-

Outstanding December 31, 2019

97,264

$

9.47

7.5

Granted

-

-

-

Exercised

-

-

-

Forfeited

-

-

-

Outstanding December 31, 2020

97,264

$

9.47

6.5

Of the SSARs outstanding at December 31, 2020, 76,897 vested and were exercisable. SSARs vest over a three year period – 33% per year.

Schedule of Compensation Cost for Share-Based Payment Arrangements, Allocation of Share-Based Compensation Costs by Plan

(dollars in thousands)

2020

2019

2018

Stock-based compensation expense:

Director stock incentive plan

$

434

$

240

$

237

Omnibus stock incentive plan

740

611

500

Employee stock purchase plan

27

107

143

Total stock-based compensation expense

$

1,201

$

958

$

880

In addition, during 2020, 2019 and 2018 the Company reversed accruals of ($0.1 million), ($0.1 million) and ($0.1 million) in stock-based compensation expense for restricted stock and SSARs to be awarded under the Omnibus Plan.

Schedule of Unrecognized Compensation Cost, Non-Vested Awards

As of

(dollars in thousands)

December 31, 2020

Unrecognized stock-based compensation expense:

Director plan

$

271

Omnibus plan

709

Total unrecognized stock-based compensation expense

$

980

The unrecognized stock-based compensation expense as of December 31, 2020 will be recognized ratably over the periods ended January 2023 and April 2023 for the Director Plan and the Omnibus Plan, respectively.